Zuellig Pharma Unveils State-of-the-Art Clinical Trial Support Innovation Center in South Korea to Support Both Domestic and Global Clinical Research Needs

Core Insights - Zuellig Pharma has launched a new Clinical Trial Support Innovation Center in South Korea, which is positioned to be the most advanced automated hub for clinical logistics in the country, enhancing its role in global clinical research [1][2] Company Overview - Zuellig Pharma is a leading healthcare solutions provider in Asia, with a mission to improve healthcare accessibility across the region. The company has a century-long history and operates in 18 markets, employing over 12,000 staff and serving more than 200,000 medical facilities [11] Facility Details - The new facility spans 3,800 square meters and is strategically located near the Gyeongbu Expressway in Gyeonggi-do province. It aims to set new standards in clinical trial logistics through automation, digitalization, and compliance with Good Practice (GxP) [3][4] - Equipped with advanced capabilities, the facility features a fully automated order fulfillment system, enhancing the speed, accuracy, and reliability of clinical supply delivery [5] - The center supports comprehensive temperature-zone management for thousands of unique clinical trial SKUs, ensuring precise handling of temperature-sensitive products throughout the supply chain [6] Operational Impact - The facility's specialized repackaging infrastructure is designed to meet stringent clinical and regulatory standards, ensuring product integrity during the clinical trial lifecycle. It includes an integrated tracking and monitoring system for full chain-of-custody and compliance [7] - Over the past year, the center has supported more than 3,000 studies in collaboration with over 100 clients, managing approximately 13,000 outbound shipments annually, including various therapeutic products [9] Market Position - As of 2025, South Korea ranks among the top 10 clinical trial markets globally and has the third-largest number of R&D pipelines. The new facility is built to meet the rising demand for clinical trial support, aiming to improve patient access and outcomes worldwide [8]